日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Impact of Disease Activity and Medications on Pregnancy and Fetal Outcomes in Women With Inflammatory Bowel Disease: A Cohort Study From the IBD-ME Group

疾病活动度和药物治疗对炎症性肠病女性妊娠及胎儿结局的影响:来自IBD-ME组的一项队列研究

Azzam, Nahla; Almadi, Majid; Alfarhan, Heba; Altuwaijiri, Mansour; Aljebreen, Abdulrahman; Alharbi, Othman; Abaalkhail, Mohammed; Jaran, Maryam; Altamimi, Abdulaziz; Al Theneyan, Abdullah; Al Turki, Nouf; Alharbi, Lubna; Ghamdi, Joud A L; Al Dakhil, Amal; Mosli, Mahmoud

Prevalence and Clinical Correlates of Fibromyalgia Screening Positivity in Patients with Inflammatory Bowel Disease

炎症性肠病患者中纤维肌痛筛查阳性的患病率和临床相关性

Mustafa, Mohammad; Bawazir, Yasser; Mukhtar, Mariam; Mosli, Mahmoud; Butt, Nadeem; Jahhaf, Jana; Alghamdi, Khalid; Alsolaimani, Roaa

Cost calculation model of introducing Upadacitinib and Risankizumab for adult ulcerative colitis and Crohn's disease in the Kingdom of Saudi Arabia

在沙特阿拉伯王国引入乌帕替尼和利沙珠单抗治疗成人溃疡性结肠炎和克罗恩病的成本计算模型

Mosli, Mahmoud H; Almutairdi, Abdulelah A; Alshahrani, Abdullah M; Alkhurmi, Abdulrahman M; Fasseeh, Ahmad N; Anwar, Ali M; Alharbi, Bandar M; Altawil, Esraa S; Alshareef, Haneen J; Alqasim, Hussain A; Alharbi, Ibtisam H; El-Fass, Kareem A; Alanizy, Layla N; Almehizia, Rayd A; Hren, Rok; Iskandarani, Wael K; Alabdulkarim, Hana A

Acute Severe Ulcerative Colitis: An International Delphi Consensus on Clinical Trial Design and Endpoints

急性重症溃疡性结肠炎:临床试验设计和终点的国际德尔菲共识

Honap, Sailish; Jairath, Vipul; Sands, Bruce E; Dulai, Parambir S; Higgins, Peter D R; De Cruz, Peter; Gutiérrez, Ana; Kotze, Paulo G; Ye, Byong Duk; Kobayashi, Taku; Gearry, Richard B; Olivera, Pablo A; Amiot, Aurélien; Mosli, Mahmoud H; Al Awadhi, Sameer; Halfvarson, Jonas; Patel, Kamal V; Sebastian, Shaji; Danese, Silvio; Peyrin-Biroulet, Laurent

Assessing the impact of magnesium-based nutritional education on lipid profiles in individuals with type 2 diabetes mellitus: a quasi-experimental study

评估镁营养教育对2型糖尿病患者血脂谱的影响:一项准实验研究

Albajri, Eram; Almasaudi, Arwa S; Mosli, Hala H; Hakim, Noor A; Basaqr, Reem O; Naseeb, Manal

High-Throughput Whole-Exome Sequencing and Large-Scale Computational Analysis to Identify the Genetic Biomarkers to Predict the Vedolizumab Response Status in Inflammatory Bowel Disease Patients from Saudi Arabia

利用高通量全外显子组测序和大规模计算分析,识别预测沙特阿拉伯炎症性肠病患者对维多珠单抗反应状态的遗传生物标志物

Aljohani, Hanin; Anbarserry, Doaa; Mosli, Mahmoud; Ujaimi, Amani; Bakhshwin, Duaa; Elango, Ramu; Alharthi, Sameer

Mapping the Ulcerative Colitis Patient Journey in Saudi Arabia from Healthcare Professionals' Perspective: A Cross-Sectional Non-Interventional Study

从医疗专业人员的角度绘制沙特阿拉伯溃疡性结肠炎患者的就医历程:一项横断面非干预性研究

Azzam, Nahla; Mosli, Mahmoud; Almutairdi, Abdulelah; Alghamdi, Mesfer; Meeralam, Yaser; Alolimi, Khalid; Arsalan, Mohammad; Al-Bawardy, Badr

Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents

沙特阿拉伯关于儿童和青少年炎症性肠病诊断和治疗的共识指南

Saadah, Omar I; AlAmeel, Turki; Al Sarkhy, Ahmed; Hasosah, Mohammed; Al-Hussaini, Abdulrahman; Almadi, Majid A; Al-Bawardy, Badr; Altuwaijri, Talal A; AlEdreesi, Mohammed; Bakkari, Shakir A; Alharbi, Othman R; Azzam, Nahla A; Almutairdi, Abdulelah; Alenzi, Khalidah A; Al-Omari, Bedor A; Almudaiheem, Hajer Y; Al-Jedai, Ahmed H; Mosli, Mahmoud H

The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group

维多珠单抗治疗既往接受过治疗的晚期溃疡性结肠炎患者的疗效:来自中东炎症性肠病(IBD-ME)注册研究组的真实世界数据

Azzam, Nahla; Alharbi, Othman; Altuwaijri, Mansour; Alruthia, Yazed; Alfarhan, Heba; Alshankiti, Suliman; Nafisah, Faris; Ajlan, Qusay; Aljebreen, Abdulrahman; Almadi, Majid; Mosli, Mahmoud H

A bibliometric analysis of inflammatory bowel disease research in the Arab world

阿拉伯世界炎症性肠病研究的文献计量分析

AlMuhaidib, Shadan; Bzeizi, Khalid; AlAmeel, Turki; Mosli, Mahmoud; Khoja, Basmah; Barakeh, Duna; Alomaim, Waleed S; Alqahtani, Saleh A; Al-Bawardy, Badr